Serum Albumin Targeted,pH‐Dependent Magnetic Resonance Relaxation Agents

The objective of this work was the synthesis of serum albumin targeted, Gd^III‐based magnetic resonance imaging (MRI) contrast agents exhibiting a strong pH‐dependent relaxivity. Two new complexes ( Gd‐glu and Gd‐bbu ) were synthesized based on the DO3A macrocycle modified with three carboxyalkyl substituents α to the three ring nitrogen atoms, and a biphenylsulfonamide arm. The sulfonamide nitrogen coordinates the Gd in a pH‐dependent fashion, resulting in a decrease in the hydration state, q, as pH is increased and a resultant decrease in relaxivity (r₁). In the absence of human serum albumin (HSA), r₁ increases from 2.0 to 6.0 mM ^?1 s^?1 for Gd‐glu and from 2.4 to 9.0 mM ^?1 s^?1 for Gd‐bbu from pH 5 to 8.5 at 37 °C, 0.47 T, respectively. These complexes (0.2 mM ) are bound (>98.9 %) to HSA (0.69 mM ) over the pH range 5–8.5. Binding to albumin increases the rotational correlation time and results in higher relaxivity. The r₁ increased 120 % (pH 5) and 550 % (pH 8.5) for Gd‐glu and 42 % (pH 5) and 260 % (pH 8.5) for Gd‐bbu . The increases in r₁ at pH 5 were unexpectedly low for a putative slow tumbling q=2 complex. The Gd‐bbu system was investigated further. At pH 5, it binds in a stepwise fashion to HSA with dissociation constants K_d1=0.65, K_d2=18, K_d3=1360 μM . The relaxivity at each binding site was constant. Luminescence lifetime titration experiments with the Eu^III analogue revealed that the inner‐sphere water ligands are displaced when the complex binds to HSA resulting in lower than expected r₁ at pH 5. Variable pH and temperature nuclear magnetic relaxation dispersion (NMRD) studies showed that the increased r₁ of the albumin‐bound q=0 complexes is due to the presence of a nearby water molecule with a long residency time (1–2 ns). The distance between this water molecule and the Gd ion changes with pH resulting in albumin‐bound pH‐dependent relaxivity.     

Hexameric MnII Dendrimer as MRI Contrast Agent

A Mn^II chelating dendrimer was prepared as a contrast agent for MRI applications. The dendrimer comprises six tyrosine‐derived [Mn(EDTA)(H₂O)]^2? moieties coupled to a cyclotriphosphazene core. Variable temperature ¹⁷O NMR spectroscopy revealed a single water co‐ligand per Mn^II that undergoes fast water exchange (k_ex=(3.0±0.1)×10⁸ s^?1 at 37 °C). The 37 °C per Mn^II relaxivity ranged from 8.2 to 3.8 mM ^?1 s^?1 from 0.47 to 11.7 T, and is sixfold higher on a per molecule basis. From this field dependence a rotational correlation time was estimated as 0.45(±0.02) ns. The imaging and pharmacokinetic properties of the dendrimer were compared to clinically used [Gd(DTPA)(H₂O)]^2? in mice at 4.7 T. On first pass, the higher per ion relaxivity of the dendrimer resulted in twofold greater blood signal than for [Gd(DTPA)(H₂O)]^2?. Blood clearance was fast and elimination occurred through both the renal and hepatobiliary routes. This Mn^II containing dendrimer represents a potential alternative to Gd‐based contrast agents, especially in patients with chronic kidney disease where the use of current Gd‐based agents may be contraindicated.     

Structural and Relaxometric Characterization of Peptide Aggregates Containing Gadolinium Complexes as Potential Selective Contrast Agents in MRI

The structural and relaxometric characterization of a novel class of supramolecular aggregates, as potential tumor‐specific contrast agents in magnetic resonance imaging (MRI), is reported. The aggregates are based on a new monomer with an upsilon shape (MonY) that contains, in the same molecule, all three fundamental tasks that are required: 1) a hydrophobic moiety that allows the formation of supramolecular aggregates; 2) the bioactive CCK8 peptide for target recognition; and 3) a chelating agent able to give stable gadolinium complexes. As indicated by dynamic light scattering and small‐angle neutron scattering (SANS) measurements, MonY and its gadolinium complex MonY(Gd) aggregate in aqueous solution to give ellipsoidal micelles with a ratio between the micellar axes of ≈1.7 and an aggregation number N_agg of ≈30. There are no differences in the aggregation behavior of MonY and MonY(Gd), which indicates that the presence of metal ions, and therefore the reduction of the net charge, does not influence the aggregation behavior. When MonY or MonY(Gd) are blended with dioleoyl phosphatidylcholine (DOPC), the aggregation behavior is dictated by the tendency of DOPC to give liposomes. Only when the amount of MonY or MonY(Gd) is higher than 20 % is the coexistence of liposomes and micelles observed. The thickness d of the bilayer is estimated by SANS to be ≈35–40 Å, whereas cryogenic transmission electron microscopy images show that the diameter of the liposomes ranges from ≈50 to 150 nm. Self‐assembling micelles of MonY(Gd) present high relaxivity values (r_1p=15.03 mM ^?1 s^?1) for each gadolinium complex in the aggregate. Liposomes containing MonY(Gd) inserted in the DOPC bilayer at a molar ratio of 20:80 present slightly lower relaxivity values (r_1p=12.7 mM ^?1 s^?1), independently of their internal or external position in the liposome.     

Physicochemical Characterization of Four Gadolinium(III) DTPA‐like Complexes

The analysis of ¹⁷O NMR transverse relaxation rates and EPR transverse electronic relaxation rates for aqueous solutions of the four DTPA‐like (DTPA = diethylenetriamine‐N,N,N′,N″,N″‐pentaacetic acid) complexes, [Gd(DTPA‐PY)(H₂O)]^? (DTPA‐PY = N′‐(2‐pyridylmethyl)), [Gd(DTPA‐HP)(H₂O)₂]^? (DTPA‐HP = N′‐(2‐hydroxypropyl)), [Gd(DTPA‐H1P)(H₂O)₂]^? (DTPA‐H1P = N′‐(2‐hydroxy‐1‐phenylethyl)) and [Gd(DTPA‐H2P)(H₂O)₂] (DTPA‐H2P = N′‐(2‐hydroxy‐2‐phenylethyl)), at various temperatures allows us to understand the water exchange dynamics of these four complexes. The water‐exchange lifetime (τM) parameters for [Gd(DTPA‐PY)(H₂O)]^?, [Gd(DTPA‐HP)(H₂O)₂]^?, [Gd(DTPA‐H1P)(H₂O)₂]^? and [Gd(DTPA‐H2P)(H₂O)₂] are of 585, 98, 163, and 69 ns, respectively. Compared with [Gd(DTPA)(H₂O)]^2? (τM = 303 ns), the τM value of [Gd(DTPA‐PY)(H₂O)]^? is slightly higher, but the other three complexes values are significantly lower than those of [Gd(DTPA)(H₂O)]^2?. This difference is explained by the fact that the gadolinium(III) complexes of DTPA‐HP, DTPA‐H1P, and DTPA‐H2P have two inner‐sphere waters. The ²H longitudinal relaxation rates of the labeled diamagnetic lanthanum complex allow the calculation of its rotational correlation time (τR). The τR values calculated for DTPA‐PY, DTPA‐HP, DTPA‐H1P, and DTPA‐H2P are of 127, 110, 142 and 147 ps, respectively. These four values are higher than the value of [La(DTPA)]^2? (τR = 103 ps), because the rotational correlation time is related to the magnitude of its molecular weight.     

A Chemical Strategy for the Relaxivity Enhancement of GdIII Chelates Anchored on Mesoporous Silica Nanoparticles

Functionalised MCM‐41 mesoporous silica nanoparticles were used as carriers of Gd^III complexes for the development of nanosized magnetic resonance imaging contrast agents. Three Gd^III complexes based on the 1,4,7,10‐tetraazacyclododecane scaffold (DOTA; monoamide‐, DOTA‐ and DO3A‐like complexes) with distinct structural and magnetic properties were anchored on the silica nanoparticles functionalised with NH₂ groups. The interaction between Gd^III chelates and surface functional groups markedly influenced the relaxometric properties of the hybrid materials, and were deeply modified passing from ionic ? NH₃⁺ to neutral amides. A complete study of the structural, textural and surface properties together with a full ¹H relaxometric characterisation of these hybrid materials before and after surface modification was carried out. Particularly for the anionic complex 2 attached to MCM‐41, an impressive increase in relaxivity (r_1p) was observed (from 20.3 to 37.8 mM ^?1 s^?1, 86.2 % enhancement at 20 MHz and 310 K), mainly due to a threefold faster water exchange rate after acetylation of the surface ? NH₃⁺ ions. This high r_1p value, coupled with the large molar amount of grafted 2 onto the silica nanoparticles gives rise to a value of relaxivity per particle of 29 500 mM ^?1 s^?1, which possibly allows it to be used in molecular imaging procedures. Smaller changes were observed for the hybrid materials based on neutral 1 and 3 complexes. In fact, whereas 1 shows a weak interaction with the surface and acetylation induced only some decrease of the local rotation, complex 3 appears to be involved in a strong interaction with surface silanols. This results in the displacement of a coordinated water molecule and in a decrease of the accessibility of the solvent to the metal centre, which is unaffected by the modification of ammonium ions to neutral amides.     

Relaxivity and Transmetallation Stability of New Benzyl‐Substituted Derivatives of Gadolinium?DTPA Complexes

In our efforts of finding new specific contrast agents of higher relaxivity and selectivity, we have prepared the two new benzyl‐functionalized DTPA (‘diethylenetriamine pentaacetate’) gadolinium complexes (S)‐ 3 and (R,S)‐ 4 , and compared their properties with those of the known regioisomers (S)‐ 2 and (S)‐ 1 . The theoretical fitting of the reduced transverse relaxation rates of the ¹⁷O‐nucleus of H₂O gave values for the water‐residence time (τ_M) of 86–143 ns at 310 K, values that are not limiting the proton relaxivity at body temperature. ¹H‐NMRD (nuclear magnetic‐relaxation dispersion) Profiles showed that the relaxivity of 1 – 4 (r₁=4.3–5.1 s^?1 mM ^?1 at 20 MHz and 310 K) is higher than for the Gd? DTPA parent compound 5 . Transmetallation assessment demonstrated that all substituted compounds, except for (S)‐ 2 , are more stable than 5 . The highest stability towards Zn²⁺‐induced transmetallation was achieved with complexes 3, 1 , and 4 (in decreasing order). Apparently, the steric hindrance of the benzyl substituents in positions 5, 4, and 2, respectively, favorably reduces the accessibility of Zn ions. From a synthetic point of view, 4‐substituted DTPA complexes of type 1 are more readily accessible than 5‐substituted compounds of type 3 . Therefore, the former seem to be superior for linking substituted DTPA complexes to macromolecules or specific vectors.     

Gadolinium containing photochromic micelles as potential magnetic resonance imaging traceable drug carriers

Novel photochromic amphipathic molecules, KMR‐AZn (Gd‐DTPA‐AZCn), composed of hydrophilic Gd‐DTPA and hydrophobic alkylated azobenzene were prepared. In aqueous environment, KMR‐AZn indicated self‐assembly. The resulting aggregates were demonstrated to be able to include a hydrophobic drug substitute (hydrophobic fluorescent dye) into the internal core, and to release the included compound upon photoirradiation within 10 min through the influence of azobenzene photoisomerization. This micellar MRI contrast agent exhibited three‐ to four‐fold higher r₁ relaxivity (r₁ = 14.5–16.5 mm ^?1 s^?1, 0.47 T at 40°C) than the widely applied small molecule contrast agent Gd‐DTPA (Magnevist^®r₁ = 4.1 mm ^?1 s^?1, 0.47 T at 40°C). This dual functionality of encapsulated compound release and increased MR imaging contrast indicates that KMR‐AZn is a potential candidate for application as a lipid‐based MRI‐traceable drug carrier.     

Two Trinuclear CuII Complexes: Effect of Phosphonate Ligand on the Magnetic Property and Electrocatalytic Reactivity for Water Oxidation

Two trinuclear copper phosphonate complexes, [Cu₃(pda)₃(tBuPO₃)]?2(Et₃NH) ( 1 ) and [Cu₃(pda)₃(PhPO₃)]?2(Et₃NH) ( 2 ), have been synthesized and investigated by a combination of X‐ray crystallography, PXRD, magneto‐ and electrochemistry, EPR, in situ UV‐vis spectroelectrochemistry and DLS. The two complexes feature almost identical crystal structures, the anions of which are both supported by pda^2? and tBuPO₃^2?/PhPO₃^2? groups, bridging three five‐coordinated Cu^II atoms to form a crown‐like structure. This is the first time that trinuclear copper phosphonate complexes have been isolated and characterized. Magnetic susceptibility measurements reveal that complexes 1 and 2 both display overall ferromagnetic characters, but with different exchange interactions between the metal ions within the two clusters. The electrocatalytic activity for water oxidation of the two complexes was preliminarily investigated, which reveals that both of the two complexes can carry out electrocatalytic water oxidation in a neutral system owing to the introduction of phosphonate ligands into the complexes, with a TOF of about 0.82 s^?1 ( 1 ) and 0.58 s^?1 ( 2 ), respectively. We propose that the presence of phosphonate ligands may affect the magnetic property and catalytic activity of the complexes.     

Dual‐Modal Magnetic Resonance/Fluorescent Zinc Probes for Pancreatic β‐Cell Mass Imaging

Despite the contribution of changes in pancreatic β‐cell mass to the development of all forms of diabetes mellitus, few robust approaches currently exist to monitor these changes prospectively in vivo. Although magnetic‐resonance imaging (MRI) provides a potentially useful technique, targeting MRI‐active probes to the β cell has proved challenging. Zinc ions are highly concentrated in the secretory granule, but they are relatively less abundant in the exocrine pancreas and in other tissues. We have therefore developed functional dual‐modal probes based on transition‐metal chelates capable of binding zinc. The first of these, Gd ?1 , binds Zn^II directly by means of an amidoquinoline moiety (AQA), thus causing a large ratiometric Stokes shift in the fluorescence from λ_em=410 to 500 nm with an increase in relaxivity from r₁=4.2 up to 4.9 mM ^?1 s^?1. The probe is efficiently accumulated into secretory granules in β‐cell‐derived lines and isolated islets, but more poorly by non‐endocrine cells, and leads to a reduction in T₁ in human islets. In vivo murine studies of Gd ?1 have shown accumulation of the probe in the pancreas with increased signal intensity over 140 minutes.     

New insights into water‐soluble and water‐coordinated copper 15‐metallacrown‐5 gadolinium complexes designed for high‐field magnetic resonance imaging applications

The development of contrast agents specifically designed for high‐field magnetic resonance imaging (MRI) is required because the relaxation efficiency of classic Gd(III) contrast agents significantly decreases with increasing magnetic field strengths. With an idea of exploring the unique structure of lanthanide (Ln) 15‐MC‐5 metallacrowns, we developed a series of water‐soluble Gd(III) aqua‐complexes, bearing aminohydroxamate (glycine, α‐alanine, α‐phenylalanine and α‐tyrosine) ligands, with increasing number of water molecules directly coordinated to the Gd(III) ion: Gd(H₂O)₄[15‐MC_Cu(II)Glyha‐5](Cl)₃ ( 1 (Gd)), Gd(H₂O)₄[15‐MC_Cu(II)Alaha‐5](Cl)₃ ( 2 (Gd)), Gd(H₂O)₃[15‐MC_{Cu(II)Phalaha}‐5](Cl)₃ ( 3 (Gd)) and Gd(H₂O)₃[15‐MC_Cu(II)Tyrha‐5](Cl)₃ ( 4 (Gd)). In these systems, the Ln(III) central ion is coordinated by five oxygen donor atoms of the ligands and three or four inner‐sphere water molecules. The X‐ray crystal structure of metallacrown Ln(H₂O)_3,4[15‐MC_Cu(II)Rha‐5]³⁺ agrees with density functional theory predictions. The calculations demonstrate that the exchange of coordinated water molecules can proceed easily, resulting in increased relaxivity parameters. The longitudinal relaxivities (r₁) of 1 (Gd)– 4 (Gd) in water at ultrahigh magnetic field of 9.4 T were determined to be 11.5, 14.8, 13.9 and 12.2 mM^?1 s^?1, respectively. The ability to increase the number of Ln(III) inner‐sphere water molecules up to four, the planar metallacrown structure and the rich hydration shell due to strong hydrogen bonds between the [15‐MC‐5] moiety and bulk water molecules provide new opportunities for potential MRI applications.     

Synthesis of lanthanide(III) complexes appended with a diphenylphosphinamide and their interaction with human serum albumin

Two DOTA-based proligands bearing a pendant diphenylphosphinamide 4a and 4b were synthesised. Their Eu(III) complexes exhibit sensitised emission when excited at 270 nm via the diphenylphosphinamide chromophore. Hydration states of q = 1.5 were determined from excited state lifetime measurements (Eu.4a $ k_{{{\text{H}}_{ 2} {\text{O}}}} = 2. 1 4 \,{\text{ms}}^{ - 1} ,\;k_{{{\text{D}}_{ 2} {\text{O}}}} = 0. 6 4 \,{\text{ms}}^{ - 1} $ ; Eu.4b $ k_{{{\text{H}}_{ 2} {\text{O}}}} = 2. 6 7\, {\text{ms}}^{ - 1} ,\;k_{{{\text{D}}_{ 2} {\text{O}}}} = 1. 1 8 \,{\text{ms}}^{ - 1} $ ). In the presence of human serum albumin (HSA) (0.1 mM Eu.4a/b, 0.67 mM HSA, pH 7.4) q = 0.4 for Eu.4a ( $ k_{{{\text{H}}_{ 2} {\text{O}}}} = 1. 3 4\, {\text{ms}}^{ - 1} ,\;k_{{{\text{D}}_{ 2} {\text{O}}}} = 0. 7 5\, {\text{ms}}^{ - 1} $ ) and q = 0.6 for Eu.4b ( $ k_{{{\text{H}}_{ 2} {\text{O}}}} = 1. 8 3\, {\text{ms}}^{ - 1} ,\;k_{{{\text{D}}_{ 2} {\text{O}}}} = 1.0 5 \,{\text{ms}}^{ - 1} $ ). Relaxivites (pH 7.4, 298 K, 20 MHz) of the Gd(III) complexes in the absence and presence of HSA (0.1 mM Gd.4a/b, 0.67 mM HSA) were: Gd.4a (r ₁ = 7.6 mM^?1s^?1 and r ₁ = 11.7 mM^?1s^?1) and Gd.4b. (r ₁ = 7.3 mM^?1s^?1 and r ₁ = 16.0 mM^?1s^?1). These relatively modest increases in r ₁ are consistent with the change in inner-sphere hydration on binding to HSA shown by luminescence measurements on Eu.4a/b. Binding constants for HSA determined by the quenching of luminescence (Eu) and enhancement of relaxivity (Gd) were Eu.4a (27,000 M^?1 ± 12%), Eu.4b (32,000 M^?1 ± 14%), Gd.4a (21,000 M^?1 ± 15%) and Gd.4b (26,000 M^?1 ± 15%).     

Approaching the Kinetic Inertness of Macrocyclic Gadolinium(III)‐Based MRI Contrast Agents with Highly Rigid Open‐Chain Derivatives

A highly rigid open‐chain octadentate ligand (H₄cddadpa) containing a diaminocylohexane unit to replace the ethylenediamine bridge of 6,6′‐[(ethane‐1,2 diylbis{(carboxymethyl)azanediyl})bis(methylene)]dipicolinic acid (H₄octapa) was synthesized. This structural modification improves the thermodynamic stability of the Gd³⁺ complex slightly (log K_GdL=20.68 vs. 20.23 for [Gd(octapa)]^?) while other MRI‐relevant parameters remain unaffected (one coordinated water molecule; relaxivity r₁=5.73 mm ^?1 s^?1 at 20 MHz and 295 K). Kinetic inertness is improved by the rigidifying effect of the diaminocylohexane unit in the ligand skeleton (half‐life of dissociation for physiological conditions is 6 orders of magnitude higher for [Gd(cddadpa)]^? (t_1/2=1.49×10⁵ h) than for [Gd(octapa)]^?. The kinetic inertness of this novel chelate is superior by 2–3 orders of magnitude compared to non‐macrocyclic MRI contrast agents approved for clinical use.     

Synthesis and Characterization of a Hypoxia‐Sensitive MRI Probe

Tissue hypoxia occurs in pathologic conditions, such as cancer, ischemic heart disease and stroke when oxygen demand is greater than oxygen supply. An imaging method that can differentiate hypoxic versus normoxic tissue could have an immediate impact on therapy choices. In this work, the gadolinium(III) complex of 1,4,7,10‐tetraazacyclododecane‐1,4,7,10‐tetraacetic acid (DOTA) with a 2‐nitroimidazole attached to one carboxyl group via an amide linkage was prepared, characterized and tested as a hypoxia‐sensitive MRI agent. A control complex, Gd(DO3A‐monobutylamide), was also prepared in order to test whether the nitroimidazole side‐chain alters either the water proton T₁ relaxivity or the thermodynamic stability of the complex. The stabilities of these complexes were lower than that of Gd(DOTA)^? as expected for mono‐amide derivatives. The water proton T₁ relaxivity (r₁), bound water residence lifetime (τ_M) and rotational correlation time (τ_R) of both complexes was determined by relaxivity measurements, variable temperature ¹⁷O NMR spectroscopy and proton nuclear magnetic relaxation dispersion (NMRD) studies. The resulting parameters (r₁=6.38 mM ^?1 s^?1 at 20 MHz , τ_M=0.71 μs, τ_R=141 ps) determined for the nitroimidazole derivative closely parallel to those of other Gd(DO3A‐monoamide) complexes of similar molecular size. In vitro MR imaging experiments with 9L rat glioma cells maintained under nitrogen (hypoxic) versus oxygen (normoxic) gas showed that both agents enter cells but only the nitroimidazole derivative was trapped in cells maintained under N₂ as evidenced by an approximately twofold decrease in T₁ measured for hypoxic cells versus normoxic cells exposed to this agent. These results suggest that the nitroimidazole derivative might serve as a molecular reporter for discriminating hypoxic versus normoxic tissues by MRI.     

Dysprosium Complexes and Their Micelles as Potential Bimodal Agents for Magnetic Resonance and Optical Imaging

Six diethylene triamine pentaacetic acid (DTPA) bisamide derivatives functionalized with p‐toluidine (DTPA‐BTolA), 6‐aminocoumarin (DTPA‐BCoumA), 1‐naphthalene methylamine (DTPA‐BNaphA), 4‐ethynylaniline (DTPA‐BEthA), p‐dodecylaniline (DTPA‐BC₁₂PheA) and p‐tetradecyl‐aniline (DTPA‐BC₁₄PheA) were coordinated to dysprosium(III) and the magnetic and optical properties of the complexes were examined in detail. The complexes consisting of amphiphilic ligands (DTPA‐BC₁₂PheA and DTPA‐BC₁₄PheA) were further assembled into mixed micelles. Upon excitation into the ligand levels, the complexes display characteristic Dy^III emission with quantum yields of 0.3–0.5 % despite the presence of one water molecule in the first coordination sphere. A deeper insight into the energy‐transfer processes has been obtained by studying the photophysical properties of the corresponding Gd^III complexes. Since the luminescence quenching effect is decreased by the intervention of non‐ionic surfactant, quantum yields up to 1 % are obtained for the micelles. The transverse relaxivity r₂ per Dy^III ion at 500 MHz and 310 K reaches a maximum value of 27.4 s^?1 mM ^?1 for Dy‐DTPA‐BEthA and 36.0 s^?1 mM ^?1 for the Dy‐DTPA‐BC₁₂PheA assemblies compared with a value of 0.8 s^?1 mM ^?1 for Dy‐DTPA. The efficient T₂ relaxation, especially at high magnetic field strengths, is sustained by the high magnetic moment of the dysprosium ion, the coordination of water molecules with slow water exchange kinetics and long rotational correlation times. These findings open the way to the further development of bimodal optical and magnetic resonance imaging probes starting from single lanthanide compounds.     

Thermal dehydration kinetics of a rare earth hydroxide,Gd(OH)3

This paper reports the synthesis, characterization, and dehydration kinetics of a rare earth hydroxide, Gd(OH)₃. Uniform rod‐like Gd(OH)₃ powder was prepared by a colloidal hydrothermal method. The powder thus obtained dehydrated into its oxide form in a two‐step process, where crystalline GdOOH was obtained as the intermediate phase. Crystal structure study revealed a monoclinic structure for GdOOH, with space group P2/1m and lattice parameters a = 6.0633, b = 3.7107, c = 4.3266, and β = 108.669. The first‐step dehydration follows the F2 mechanism, while the second step follows the F1 model, indicating that both the steps are controlled by nucleation/growth mechanism. The activation energy E_a and frequency factor A are 231±12 kJ/mol and 2.08 × 1018 s^?1 for the first step and 496 ± 32 kJ/mol and 7.88 × 10³³ s^?1 for the second step, respectively. Such high activation energy calculated from the experimental data can be ascribed to the high bonding energy of Gd? O bond, and the difference in activation energy for the two steps is due to the change in the bond length of hexagonal Gd(OH)₃ and monoclinic GdOOH. © 2006 Wiley Periodicals, Inc. Int J Chem Kinet 39: 75–81, 2007     

Tetraphenylporphyrin‐based dual‐functional medical agent for magnetic resonance and fluorescence imaging

A bimodal magnetic resonance imaging contrast agent, TPP‐M‐Gd, was developed by modifying tetraphenylporphyrin (TPP) with a small dendritic molecule as a ligand (M) to chelate gadolinium (Gd) ions. The ligand featured four carboxylate groups, which contributed to good water solubility and a strong combination with metal ions. The longitudinal relaxivity (R₁) of the resulting agent was calculated to be 12.45 mM^?1 s^?1, which is much higher than that of DTPA‐Gd (4.49 mM^?1 s^?1). The magnetic resonance imaging experiments showed that the newly synthesized contrast agent could enhance T₁‐weighted magnetic resonance imaging quality both in vitro and in vivo. In addition, TPP‐M‐Gd exhibited good fluorescent property as shown in cell imaging experiments. The cytotoxicity of TPP‐M‐Gd was even better than that of clinically approved DTPA‐Gd, which makes it a promising dual‐functional medical imaging agent to provide more detailed information about biological and disease‐related events.     

Low‐Dimensional Carboxylate‐Bridged GdIII Complexes for Magnetic Refrigeration

Four carboxylate‐bridged Gd^III complexes ( 1 – 4 ) with 1D/2D structures have been synthesized by using the hydrothermal reaction of Gd₂O₃ with various carboxylate ligands. Compounds 1 and 2 contained the same [2n] Gd^III? OH ladders, but with different crystallographically independent Gd^III ions, whilst the structures of compounds 3 and 4 were composed of [Gd₄(μ₃‐OH)₂(piv)₈(H₂O)₂]²⁺ units and 1D ladder Gd^III chains, respectively. Antiferromagnetic interactions occurred in compounds 1 – 3 , owing to their small Gd? O? Gd angles, whereas ferromagnetic coupling occurred in compound 4 , in which the Gd? O? Gd angles were larger. These complexes exhibited a distinct magnetocaloric effect (MCE), which was affected by their different magnetic densities and exchange interactions. Among these compounds, complex 4 presented the largest MCE (?ΔS_m^max=43.6 J kg^?1 K^?1), the lowest M_w/N_Gd ratio (the highest magnetic density), and weak ferromagnetic coupling. Therefore, a lower M_w/N_Gd ratio and weaker exchange interactions (a smaller absolute value of θ) between Gd^III ions resulted in a larger MCE for the Gd^III complexes.     

General Protocol for the Synthesis of Functionalized Magnetic Nanoparticles for Magnetic Resonance Imaging from Protected Metal–Organic Precursors

The development of magnetic nanoparticles (MNPs) with functional groups has been intensively pursued in recent years. Herein, a simple, versatile, and cost‐effective strategy to synthesize water‐soluble and amino‐functionalized MNPs, based on the thermal decomposition of phthalimide‐protected metal–organic precursors followed by deprotection, was developed. The resulting amino‐functionalized Fe₃O₄, MnFe₂O₄, and Mn₃O₄ MNPs with particle sizes of about 14.3, 7.5, and 6.6 nm, respectively, had narrow size distributions and good dispersibility in water. These MNPs also exhibited high magnetism and relaxivities of r₂=107.25 mM^?1 s^?1 for Fe₃O₄, r₂=245.75 mM^?1 s^?1 for MnFe₂O₄, and r₁=2.74 mM^?1 s^?1 for Mn₃O₄. The amino‐functionalized MNPs were further conjugated with a fluorescent dye (rhodamine B) and a targeting ligand (folic acid: FA) and used as multifunctional probes. Magnetic resonance imaging and flow‐cytometric studies showed that these probes could specifically target cancer cells overexpressing FA receptors. This new protocol opens a new way for the synthesis and design of water‐soluble and amino‐functionalized MNPs by an easy and versatile route.     

Magnetocaloric Properties of Heterometallic 3d–Gd Complexes Based on the [Gd(oda)3]3− Metalloligand

A series of heterometallic 3d–Gd³⁺ complexes based on a lanthanide metalloligand, [M(H₂O)₆][Gd(oda)₃] ? 3 H₂O [M=Cr³⁺ ( 1‐Cr )] (H₂oda=2,2′‐oxydiacetic acid), [M(H₂O)₆][MGd(oda)₃]₂ ? 3 H₂O [M=Mn²⁺ ( 2‐Mn ), Fe²⁺ ( 2‐Fe ) and Co²⁺ ( 2‐Co )], and [M₃Gd₂(oda)₆(H₂O)₆] ? 12 H₂O [M=Ni²⁺ ( 3‐Ni ), Cu²⁺ ( 3‐Cu ), and Zn²⁺ ( 3‐Zn )], are reported. Magnetic and heat‐capacity studies revealed a significant impact on the magnetocaloric effect depending on the anisotropy of the 3d transition metal ions, as confirmed by comparison of the observed maximum values of ?ΔS_m between complexes 2‐Co and 1‐Cr . In these two complexes, the 3d metal ions have the same spin (S=3/2 for Co²⁺ and Cr³⁺ ions), and the theoretical calculation suggested a larger ?ΔS_m value for 2‐Co (47.8 J K^?1 kg^?1) than 1‐Cr (37.5 J K^?1 kg^?1); however, the significant anisotropy of Co²⁺ ions in 2‐Co , which can result in smaller effective spins, gives a smaller value of ?ΔS_m for 2‐Co (32.2 J K^?1 kg^?1) than for 1‐Cr (35.4 J K^?1 kg^?1) at ΔH=9 T.